Westchester Capital Management (New York)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-106,988
Closed -$18.9M 209
2020
Q1
$18.9M Sell
106,988
-1,010,021
-90% -$190M 0.72% 36
2019
Q4
$214M Buy
1,117,009
+206,502
+23% +$37.3M 7.52% 1
2019
Q3
$153M Buy
910,507
+795,913
+695% +$130M 5.96% 4
2019
Q2
$19.2M Buy
+114,594
New +$15.9M 0.63% 25
2017
Q1
Sell
-28,358
Closed -$5.96M 106
2016
Q4
$5.96M Sell
28,358
-70,297
-71% -$14.6M 0.15% 70
2016
Q3
$22.7M Sell
98,655
-131,152
-57% -$32M 0.65% 45
2016
Q2
$53.1M Buy
229,807
+11,208
+5% +$2.58M 1.22% 29
2016
Q1
$58.6M Buy
218,599
+176,799
+423% +$50.6M 1.16% 33
2015
Q4
$13.1M Buy
+41,800
New +$12.4M 0.23% 67

Other funds holding AGN

Westchester Capital Management (New York)'s AGN Position: Q2 2020 in Review

Westchester Capital Management (New York) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 106,988 shares — an estimated $18.9M sold.

Westchester Capital Management (New York) first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $214M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Westchester Capital Management (New York) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 106,988 Allergan plc shares in Q2 2020, an estimated $18.9M.
  • Westchester Capital Management (New York) first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
  • Westchester Capital Management (New York)'s Allergan plc position peaked at $214M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.